Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Long Term Debt Summary of Austar Lifesciences Limited

  • Austar Lifesciences Limited's latest annual long term debt in 2023 was 162.98 Million CNY , up 306.78% from previous year.
  • Austar Lifesciences Limited's latest quarterly long term debt in 2024 Q2 was 75.53 Million CNY , down -31.86% from previous quarter.
  • Austar Lifesciences Limited reported annual long term debt of 40.06 Million CNY in 2022, down -26.17% from previous year.
  • Austar Lifesciences Limited reported annual long term debt of 54.27 Million CNY in 2021, up 67.83% from previous year.
  • Austar Lifesciences Limited reported quarterly long term debt of 162.98 Million CNY for 2023 Q4, up 181.64% from previous quarter.
  • Austar Lifesciences Limited reported quarterly long term debt of 162.98 Million CNY for 2023 FY, up 306.78% from previous quarter.

Annual Long Term Debt Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Long Term Debt of Austar Lifesciences Limited (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 162.98 Million CNY 306.78%
2022 40.06 Million CNY -26.17%
2021 54.27 Million CNY 67.83%
2020 32.33 Million CNY 29.41%
2019 24.98 Million CNY 0.0%
2018 - CNY 0.0%
2017 - CNY 0.0%
2016 - CNY 0.0%
2015 - CNY 0.0%
2014 - CNY 0.0%
2013 - CNY 0.0%

Peer Long Term Debt Comparison of Austar Lifesciences Limited

Name Long Term Debt Long Term Debt Difference
Vincent Medical Holdings Limited 1.83 Million HKD -8762.751%